Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
1,077.19
-1.44 (-0.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Now May Be the Big Moment for These 2 COVID Stocks
September 02, 2021
Their products are seeing a surge in demand.
Via
The Motley Fool
Exposures
COVID-19
5 Stocks That Powered S&P 500 ETF in August
September 01, 2021
The S&P 500 hit a series of record highs in August despite bouts of volatility and uncertainty.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...
Via
Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Can COVID-19 Antibody Treatment Help In High-Risk Cases? Mayo Clinic, nference Study Shows Potential
August 30, 2021
Mayo Clinic and nference are jointly conducting artificial intelligence-powered studies evaluating monoclonal antibodies for COVID-19 in patients with an elevated risk...
Via
Benzinga
Exposures
COVID-19
Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
August 30, 2021
Pfizer Inc (NYSE: PFE) announced topline data from the JADE DARE Phase 3 trial comparing abrocitinib with Sanofi SA (NASDAQ: SNY) - Regeneron...
Via
Benzinga
Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
August 30, 2021
A Phase 3 trial evaluating Dupixent (dupilumab) for treating children aged 6 months to 5 years with moderate-to-severe atopic dermatitis met its primary and secondary...
Via
Benzinga
Regeneron Pharmaceuticals Is My Value Stock Of The Week
August 29, 2021
Regeneron Pharmaceuticals, Inc. has become popular over the past year due to its COVID 19 cocktail treatment. It has more than a couple blockbuster drugs, with even more on the way. The best part is...
Via
Talk Markets
Market Briefing For Thursday, Aug. 26
August 26, 2021
Underperformance by many stocks, but few that are really in trouble, is reflective of rising complacency, while technicians are frustrated at the lack of breakouts or breakdowns. That's actually fine,...
Via
Talk Markets
5 Stocks At the Forefront of the Latest S&P 500 Rally
August 24, 2021
Here are five stocks in the S&P 500 that led the market higher amid the uncertainty.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
August 24, 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related...
Via
Benzinga
Return on Capital Employed Insights for Regeneron Pharmaceuticals
August 23, 2021
After pulling data from Benzinga Pro it seems like during Q2, Regeneron Pharmaceuticals (NASDAQ:REGN) earned $3.35 billion, a 200.82% increase from the preceding quarter....
Via
Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
August 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...
Via
Benzinga
Exposures
Product Safety
Tesla And The Quest For Alpha
August 23, 2021
Tesla exemplifies both the successes and failures of our security selection method. How it works and where we go from here.
Via
Talk Markets
Market Briefing For Monday, Aug. 23
August 23, 2021
We might be near a moment of truth for the Senior Indexes, either in just a few days or postponed until after Labor Day.
Via
Talk Markets
Regeneron Pharmaceutical Stock Earns 84 Relative Strength Rating
August 20, 2021
A Relative Strength Rating upgrade for Regeneron Pharmaceutical shows improving technical performance.
Via
Investor's Business Daily
Exposures
COVID-19
Stocks That Hit 52-Week Highs On Friday
August 20, 2021
Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high...
Via
Benzinga
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
August 20, 2021
The U.K. drug regulator has approved an antibody cocktail developed by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Roche Holding AG (OTC: RHHBY) to prevent...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
PreMarket Prep Stock Of The Day: Regeneron
August 18, 2021
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news...
Via
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
August 18, 2021
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs. Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market cap basis to set a new...
Via
Benzinga
5 Stocks Insiders Are Selling
August 18, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
JD.com And Tesla Lead The Nasdaq Lower Tuesday
August 17, 2021
U.S. indices were trading lower Tuesday amid macro uncertainty due to COVID-19 concerns. Investors also weighed today's Home Depot (NYSE: HD) earnings and a drop in...
Via
Benzinga
Exposures
COVID-19
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week...
Via
Benzinga
Novartis Shares Two Year Beovu Data From Diabetic Macular Edema Studies
August 17, 2021
Novartis AG (NYSE: NVS) has reported data from two Phase 3 trials assessing Beovu (brolucizumab) 6 mg versus Regeneron Pharmaceuticals Inc's (NASDAQ: REGN...
Via
Benzinga
3 Growth Stocks Cathie Wood Is Selling That Are Still Worth Buying
August 17, 2021
Wood might regret trimming her positions in these great growth stocks.
Via
The Motley Fool
Large Cap Biopharma Stocks provide Growth and Value
August 16, 2021
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.